Equity Overview
Price & Market Data
Price: $26.17
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $363,387,936
Daily Volume: 0
Performance Metrics
1 Week: -0.57%
1 Month: -9.01%
3 Months: 16.00%
6 Months: 68.95%
1 Year: 390.1%
YTD: -4.03%
Company Details
Employees: 19
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.